Text Size
772 studies found for:    "Hepatitis C, Chronic"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
22 Recruiting A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Interleukin 28B testing
23 Completed
Has Results 		Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepacivirus
Interventions: Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908)
24 Completed A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
25 Active, not recruiting A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: boceprevir;   Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin (Copegus]
26 Completed
Has Results 		Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690 AM1)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (Peginterferon alfa-2b);   Drug: Rebetol (Ribavirin)
27 Not yet recruiting Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Legalon® SIL (Silibinin);   Drug: Pegylated interferon alfa2b;   Drug: Ribavirin
28 Completed Effect of Low-Dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Biological: PegIntron (peginterferon alfa-2b)
29 Completed Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
30 Completed
Has Results 		Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538AM1 Part 1)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
31 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
32 Terminated
Has Results 		Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
Condition: Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b (PegIFN-2b);   Drug: Comparator: Stronger neo minophagen C (SNMC)
33 Recruiting An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
34 Completed A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: danoprevir;   Drug: ritonavir;   Drug: RO5024048;   Drug: Copegus;   Drug: Pegasys
35 Recruiting An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
36 Active, not recruiting Quality of Life in Chronic Hepatitis C (Study P05278)
Conditions: Hepatitis C, Chronic;   Genotype 1;   HCV-1
Interventions: Biological: Peginterferon alfa-2b;   Drug: Ribavirin
37 Recruiting Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients
Condition: Hepatitis C, Chronic
Intervention:
38 Completed A Study of Combination Treatment With PEGASYS (Peginterferon Alfa-2a (40KD) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin [Copegus]
39 Active, not recruiting Three-year Follow-up of Subjects After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063AM1)
Conditions: Hepatitis C, Chronic;   Hepacivirus
Interventions: Drug: Boceprevir (SCH 503034);   Drug: Narlaprevir (SCH 900518)
40 Active, not recruiting A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: mericitabine;   Drug: boceprevir;   Drug: Pegasys;   Drug: Copegus
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years